Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sirka Nitschmann

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Innere Medizin (Heidelberg, Germany)|December 1, 2022
[Role of SGLT-2 inhibitors in patients with heart failure and preserved ejection fraction]Robert H G Schwinger, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|December 9, 2022
[Vitamin D supplementation]Heike A Bischoff-Ferrari, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|January 6, 2026
[Paradigm shift in the first-line treatment of BRAF V600E-mutated metastatic colorectal cancer : BREAKWATER-Trial]Mirjam Richard, Sirka Nitschmann, Christine Koch
Innere Medizin (Heidelberg, Germany)|May 15, 2024
[Stroke prevention in atrial fibrillation : The ARTESIA study in the light of current knowledge]Arif Elvan, Matthias Antz, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|December 31, 2024
[Iscalimab-New treatment option for patients with primary Sjögren's disease]Arman Aue, Thomas Dörner, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|May 24, 2023
[Iron supplementation in patients with heart failure and iron deficiency]Miroslava Valentová, Karl Toischer, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|October 17, 2023
[Mirikizumab for ulcerative colitis]Laura Katharina Sievers, Stefan Schreiber, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|August 12, 2025
[Empagliflozin-Long-term effects in patients with chronic kidney disease : EMPA-KIDNEY]Philipp Scherrer, Sirka Nitschmann, Roman-Ulrich Müller
Innere Medizin (Heidelberg, Germany)|April 28, 2025
Welf-Axel Geller, Johann Bauersachs, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|January 6, 2026
[Inhibition of cholesteryl ester transfer protein (CETP) with obicetrapib to reduce cardiovascular risk : BROADWAY Trial]Maximilian Seidel, Sirka Nitschmann, Timm H Westhoff
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Innere Medizin (Heidelberg, Germany)|December 1, 2022
[Role of SGLT-2 inhibitors in patients with heart failure and preserved ejection fraction]Robert H G Schwinger, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|December 9, 2022
[Vitamin D supplementation]Heike A Bischoff-Ferrari, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|January 6, 2026
[Paradigm shift in the first-line treatment of BRAF V600E-mutated metastatic colorectal cancer : BREAKWATER-Trial]Mirjam Richard, Sirka Nitschmann, Christine Koch
Innere Medizin (Heidelberg, Germany)|May 15, 2024
[Stroke prevention in atrial fibrillation : The ARTESIA study in the light of current knowledge]Arif Elvan, Matthias Antz, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|December 31, 2024
[Iscalimab-New treatment option for patients with primary Sjögren's disease]Arman Aue, Thomas Dörner, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|May 24, 2023
[Iron supplementation in patients with heart failure and iron deficiency]Miroslava Valentová, Karl Toischer, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|October 17, 2023
[Mirikizumab for ulcerative colitis]Laura Katharina Sievers, Stefan Schreiber, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|August 12, 2025
[Empagliflozin-Long-term effects in patients with chronic kidney disease : EMPA-KIDNEY]Philipp Scherrer, Sirka Nitschmann, Roman-Ulrich Müller
Innere Medizin (Heidelberg, Germany)|April 28, 2025
Welf-Axel Geller, Johann Bauersachs, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|January 6, 2026
[Inhibition of cholesteryl ester transfer protein (CETP) with obicetrapib to reduce cardiovascular risk : BROADWAY Trial]Maximilian Seidel, Sirka Nitschmann, Timm H Westhoff
Pageof 6